ViewsML
Transforming Precision Medicine and Diagnostics with Virtual Biomarker Staining
Vancouver, United States · $4.9M raised
- Headquarters
- Vancouver
- Employees
- 1–10
- Business Model
- B2B
- Website
- viewsml.com
- Total Funding
- $4.9M
- Last Round
- $4.9M SeedApr 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
ViewsML uses deep learning to convert routine pathology images into virtual biomarker staining results, eliminating time-consuming and tissue-destructive lab processes. Its platform provides per-cell spatial and quantitative biomarker insights from a single H&E slide, serving pharmaceutical companies, diagnostic labs, and healthcare systems pursuing faster, more scalable precision medicine.
Summary
ViewsML is an Artificial Intelligence company based in Vancouver, United States. It has raised $4.9M in total across 1 round, most recently a $4.9M Seed round in Apr 2026. Investors include Wittington Ventures and Mayo Clinic.
Tech & App Stack
8 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2026
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/viewsml"><img src="https://indexed.vc/api/badge/company/viewsml" alt="ViewsML on Indexed.vc" width="260" height="76" /></a>
